New York State Common Retirement Fund Akebia Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 79,100 shares of AKBA stock, worth $134,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,100
Previous 79,100 -0.0%
Holding current value
$134,470
Previous $287,000 25.78%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Oct 08, 2025
BUY
$1.55 - $3.97 $63,085 - $161,579
40,700 Added 105.99%
79,100 $287,000
Q2 2025

Aug 13, 2025
BUY
$1.55 - $3.97 $63,085 - $161,579
40,700 Added 105.99%
79,100 $288,000
Q1 2025

Oct 08, 2025
BUY
$1.69 - $2.84 $43,771 - $73,556
25,900 Added 207.2%
38,400 $73,000
Q1 2025

May 01, 2025
BUY
$1.69 - $2.84 $43,771 - $73,556
25,900 Added 207.2%
38,400 $74,000
Q3 2024

Oct 08, 2025
SELL
$0.94 - $1.55 $62,604 - $103,230
-66,600 Reduced 84.2%
12,500 $16,000
Q3 2024

Oct 28, 2024
SELL
$0.94 - $1.55 $83,284 - $137,330
-88,600 Reduced 87.64%
12,500 $17,000
Q2 2024

Oct 08, 2025
BUY
$0.86 - $1.63 $18,920 - $35,860
22,000 Added 27.81%
101,100 $103,000
Q2 2024

Jul 31, 2024
BUY
$0.86 - $1.63 $86,946 - $164,793
101,100 New
101,100 $103,000
Q2 2022

Aug 04, 2022
SELL
$0.32 - $0.67 $39,168 - $82,009
-122,402 Reduced 98.71%
1,595 $1,000
Q1 2022

May 05, 2022
BUY
$0.72 - $2.93 $93 - $380
130 Added 0.1%
123,997 $89,000
Q4 2021

Feb 02, 2022
BUY
$2.26 - $3.34 $84,006 - $124,151
37,171 Added 42.88%
123,867 $280,000
Q3 2021

Nov 02, 2021
SELL
$2.35 - $3.88 $79,411 - $131,112
-33,792 Reduced 28.05%
86,696 $250,000
Q2 2021

Aug 02, 2021
BUY
$2.83 - $4.2 $3,356 - $4,981
1,186 Added 0.99%
120,488 $457,000
Q2 2020

Aug 07, 2020
BUY
$6.67 - $13.58 $102,718 - $209,132
15,400 Added 14.82%
119,302 $1.62 Million
Q1 2020

May 06, 2020
BUY
$4.1 - $10.24 $28,699 - $71,680
7,000 Added 7.22%
103,902 $788,000
Q4 2019

Feb 05, 2020
SELL
$3.16 - $6.73 $76,472 - $162,866
-24,200 Reduced 19.98%
96,902 $612,000
Q2 2019

Aug 09, 2019
BUY
$4.1 - $8.05 $167,280 - $328,440
40,800 Added 50.81%
121,102 $586,000
Q4 2018

Feb 08, 2019
BUY
$5.39 - $9.15 $180,575 - $306,543
33,502 Added 71.59%
80,302 $444,000
Q3 2018

Nov 07, 2018
SELL
$7.44 - $10.65 $113,608 - $162,625
-15,270 Reduced 24.6%
46,800 $413,000
Q2 2018

Aug 10, 2018
BUY
$9.15 - $11.34 $86,010 - $106,596
9,400 Added 17.85%
62,070 $619,000
Q4 2017

Feb 13, 2018
BUY
$14.24 - $19.59 $65,076 - $89,526
4,570 Added 9.5%
52,670 $783,000
Q2 2017

Aug 11, 2017
BUY
N/A
48,100
48,100 $691,000

Others Institutions Holding AKBA

# of Institutions
191
Shares Held
121M
Call Options Held
267K
Put Options Held
280K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $313M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email